| NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis L Arruvito, S Giulianelli, AC Flores, N Paladino, M Barboza, C Lanari, ... The Journal of Immunology 180 (8), 5746-5753, 2008 | 187 | 2008 |
| The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer C Lanari, CA Lamb, VT Fabris, LA Helguero, R Soldati, MC Bottino, ... Endocrine-related cancer 16 (2), 333, 2009 | 151 | 2009 |
| Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALBc female mice C Lanari, AA Molinolo, CD Pasqualini Cancer letters 33 (2), 215-223, 1986 | 148 | 1986 |
| AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins M Riggio, MC Perrone, ML Polo, MJ Rodriguez, M May, M Abba, C Lanari, ... Scientific reports 7 (1), 44244, 2017 | 129 | 2017 |
| Five Novel Hormone-responsive Cell Lines Derived from Murine Mammary Ductal Carcinomas: In Vivo and in Vitro Effects of Estrogens and Progestins C Lanari, I Lüthy, CA Lamb, V Fabris, E Pagano, LA Helguero, ... Cancer research 61 (1), 293-302, 2001 | 129 | 2001 |
| α2‐Adrenoceptor action on cell proliferation and mammary tumour growth in mice A Bruzzone, CP Pinero, LF Castillo, MG Sarappa, P Rojas, C Lanari, ... British journal of pharmacology 155 (4), 494-504, 2008 | 125 | 2008 |
| Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells CZ Cotrim, V Fabris, ML Doria, K Lindberg, JÅ Gustafsson, F Amado, ... Oncogene 32 (19), 2390-2402, 2013 | 120 | 2013 |
| Carcinoma‐associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: a role for the FGF‐2/FGFR‐2 axis S Giulianelli, JP Cerliani, CA Lamb, VT Fabris, MC Bottino, MA Gorostiaga, ... International journal of cancer 123 (11), 2518-2531, 2008 | 117 | 2008 |
| Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters S Giulianelli, JP Vaqué, R Soldati, V Wargon, SI Vanzulli, R Martins, ... Cancer research 72 (9), 2416-2427, 2012 | 116 | 2012 |
| Antiprogestins in breast cancer treatment: are we ready? CLM Lanari, V Wargon, PA Rojas, A Molinolo BioScientifica, 2012 | 114 | 2012 |
| Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors. AA Molinolo, C Lanari, EH Charreau, N Sanjuan, CD Pasqualini Journal of the National Cancer Institute 79 (6), 1341-1350, 1987 | 110 | 1987 |
| Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer JP Cerliani, T Guillardoy, S Giulianelli, JP Vaque, JS Gutkind, SI Vanzulli, ... Cancer research 71 (10), 3720-3731, 2011 | 107 | 2011 |
| Progesterone receptors-animal models and cell signaling in breast cancer Diverse activation pathways for the progesterone receptor-possible implications for breast biology and … C Lanari, AA Molinolo Breast Cancer Research 4, 1-4, 2002 | 79 | 2002 |
| Progesterone receptor isoform ratio: a breast cancer prognostic and predictive factor for antiprogestin responsiveness PA Rojas, M May, GR Sequeira, A Elia, M Alvarez, P Martínez, ... JNCI: Journal of the National Cancer Institute 109 (7), djw317, 2017 | 78 | 2017 |
| Mammary adenocarcinomas induced by medroxyprogesterone acetate: Hormone dependence and egf receptors of BALB/c In vivo sublines C Lanari, E Kordon, A Molinolo, CD Pasqualini, EH Charreau International journal of cancer 43 (5), 845-850, 1989 | 70 | 1989 |
| Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma G Dran, IA Luthy, AA Molinolo, F Montecchia, EH Charreau, ... Breast cancer research and treatment 35, 173-186, 1995 | 66 | 1995 |
| Mammary carcinogenesis induced byN-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) inBALB/c mice P Pazos, C Lanari, R Meiss, EH Charreau, C Dosne Pasqualini Breast cancer research and treatment 20, 133-138, 1991 | 61 | 1991 |
| Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters V Wargon, M Riggio, S Giulianelli, GR Sequeira, P Rojas, M May, ML Polo, ... International journal of cancer 136 (11), 2680-2692, 2015 | 57 | 2015 |
| PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer M Riggio, ML Polo, M Blaustein, A Colman-Lerner, I Lüthy, C Lanari, ... Carcinogenesis 33 (3), 509-518, 2012 | 57 | 2012 |
| α2-Adrenoceptors enhance cell proliferation and mammary tumor growth acting through both the stroma and the tumor cells A Bruzzone, C Perez Pinero, P Rojas, M Romanato, H Gass, C Lanari, ... Current cancer drug targets 11 (6), 763-774, 2011 | 56 | 2011 |
